Quantcast
Last updated on April 23, 2014 at 11:04 EDT

Latest Opioids Stories

2012-07-02 06:24:39

BIRMINGHAM, Ala. and SHREVEPORT, La., July 2, 2012 /PRNewswire-USNewswire/ -- Using preclinical molecular imaging, scientists from Southern Research Institute and LSU Health Sciences Center in Shreveport have published data which could lead to better diagnosis and treatment of Parkinson's disease. Their study--"PET Imaging a MPTP-Induced Mouse Model of Parkinson's Disease Using the Fluoropropyl-Dihydrotetrabenazine Analog [18F]-DTBZ (AV-133)"--was published in a recent edition (June 18,...

2012-06-28 10:25:43

SAN DIEGO, June 28, 2012 /PRNewswire/ -- Millennium Laboratories, the leading research-based clinical diagnostic company dedicated to improving the lives of people suffering from pain, announced today the introduction of Millennium Pharmacogenetic Testing (PGT). Millennium PGT is saliva-based testing to detect genetic variations in enzymes associated with the metabolism of medications commonly prescribed to patients suffering from debilitating chronic pain and pain-related effects. This...

2012-06-28 02:27:49

REDWOOD CITY, Calif., June 28, 2012 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that Richard King, President and Chief Executive Officer, will present at JMP Securities Healthcare Conference 2012 in New York City at The Peninsula New York Hotel. The presentation is scheduled for Thursday, July 12, 2012...

2012-06-28 02:27:38

RALEIGH, N.C., June 28, 2012 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced positive results of a recently completed pharmacokinetic study (BNX-106) examining the effects of multiple BEMA Buprenorphine/Naloxone (BNX) films administered concurrently. This study was part of the U.S. Food and Drug Administration (FDA) recommended program for a New Drug Application (NDA) for BNX. (Logo: http://photos.prnewswire.com/prnh/20110217/CL49801LOGO ) The study...

2012-06-25 23:01:56

According to court documents, on June 19th, 2012, Tracy King filed a wrongful death claim at Philadelphia´s Common Pleas Court (case no. 120602334) alleging that her sister´s death was caused by a Fentanyl pain patch. Fentanyl (brand names Duragesic, Onsolis and others) is a potent synthetic narcotic analgesic used to treat breakthrough cancer pain and is commonly used in pre-procedures as a pain reliever as well as an anesthetic. On April 18th 2012, the US FDA reminded patients,...

2012-06-25 02:25:50

RALEIGH, N.C., June 25, 2012 /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced today that the Company has been added to the Russell 3000(®) and Russell 2000(®) Indexes following the reconstitution of the Russell U.S. and global equity indexes. (Logo: http://photos.prnewswire.com/prnh/20110217/CL49801LOGO ) Annual reconstitution of the Russell 3000 index captures the 3,000 largest U.S. stocks as of the end of May, ranking them by total market...

2012-06-20 14:17:21

Genetics play a significant role in determining which patients will suffer the most from the disturbing side effects of opiates, commonly prescribed painkillers for severe to moderate pain, according to a new Stanford University School of Medicine study, which pinpoints nausea, slowed breathing and potential for addiction as heritable traits. "One of the most hated side effects of these opiates, nausea, is strongly inherited," said Martin Angst, MD, professor of anesthesia and one of two...

2012-06-20 02:26:38

REDWOOD CITY, Calif., June 20, 2012 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that the U.S. Patent and Trademark Office (USPTO) issued AcelRx Patent Number 8,202,535 entitled "Small-Volume Oral Transmucosal Dosage Forms." The patent describes a method of treating pain by administering a...

2012-06-18 06:28:40

NEW PORT RICHEY, Fla., June 18, 2012 /PRNewswire/ -- While detox programs can help opiate abusers overcome their addiction, Novus Medical Detox Director Kirk Burness warns rapid detox has risks of its own. In light of the dangers associated with both opiate use and rapid detox, Burness advises those seeking detox treatments to opt for a medically supervised inpatient program. Globally, the World Health Organization estimates that 13.5 million people take opioids(1); and according...

2012-06-15 23:00:41

Normally used in clinical settings, Puridone has been recently released to the general public online as a 60-day "in home" treatment to help those dealing with opiate dependency and painkiller addiction. In clinical studies conducted in 2012, Puridone demonstrated a remarkable increase in energy, sleep and sex drive, while simultaneously lowering withdrawal symptoms, anxiety and depression scores. Jamison, PA (PRWEB) June 15, 2012 The Puridone Program is an incredible new proprietary...